Relationships among commercial practices and author conflicts of interest in biomedical publishing.

Recently, concerns have been raised over the potential impacts of commercial relationships on editorial practices in biomedical publishing. Specifically, it has been suggested that certain commercial relationships may make editors more open to publishing articles with author conflicts of interest (a...

Full description

Bibliographic Details
Main Authors: S Scott Graham, Zoltan P Majdik, Dave Clark, Molly M Kessler, Tristin Brynn Hooker
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0236166
_version_ 1818361887401705472
author S Scott Graham
Zoltan P Majdik
Dave Clark
Molly M Kessler
Tristin Brynn Hooker
author_facet S Scott Graham
Zoltan P Majdik
Dave Clark
Molly M Kessler
Tristin Brynn Hooker
author_sort S Scott Graham
collection DOAJ
description Recently, concerns have been raised over the potential impacts of commercial relationships on editorial practices in biomedical publishing. Specifically, it has been suggested that certain commercial relationships may make editors more open to publishing articles with author conflicts of interest (aCOI). Using a data set of 128,781 articles published in 159 journals, we evaluated the relationships among commercial publishing practices and reported author conflicts of interest. The 159 journals were grouped according to commercial biases (reprint services, advertising revenue, and ownership by a large commercial publishing firm). 30.6% (39,440) of articles were published in journals showing no evidence of evaluated commercial publishing relationships. 33.9% (43,630) were published in journals accepting advertising and reprint fees; 31.7% (40,887) in journals owned by large publishing firms; 1.2% (1,589) in journals accepting reprint fees only; and 2.5% (3,235) in journals accepting only advertising fees. Journals with commercial relationships were more likely to publish articles with aCOI (9.2% (92/1000) vs. 6.4% (64/1000), p = 0.024). In the multivariate analysis, only a journal's acceptance of reprint fees served as a significant predictor (OR = 2.81 at 95% CI, 1.5 to 8.6). Shared control estimation was used to evaluate the relationships between commercial publishing practices and aCOI frequency in total and by type. BCa-corrected mean difference effect sizes ranged from -1.0 to 6.1, and confirm findings indicating that accepting reprint fees may constitute the most significant commercial bias. The findings indicate that concerns over the influence of industry advertising in medical journals may be overstated, and that accepting fees for reprints may constitute the largest risk of bias for editorial decision-making.
first_indexed 2024-12-13T21:23:49Z
format Article
id doaj.art-6f64f93f7025415aa1cc75e758d7aa12
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-13T21:23:49Z
publishDate 2020-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-6f64f93f7025415aa1cc75e758d7aa122022-12-21T23:31:00ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-01157e023616610.1371/journal.pone.0236166Relationships among commercial practices and author conflicts of interest in biomedical publishing.S Scott GrahamZoltan P MajdikDave ClarkMolly M KesslerTristin Brynn HookerRecently, concerns have been raised over the potential impacts of commercial relationships on editorial practices in biomedical publishing. Specifically, it has been suggested that certain commercial relationships may make editors more open to publishing articles with author conflicts of interest (aCOI). Using a data set of 128,781 articles published in 159 journals, we evaluated the relationships among commercial publishing practices and reported author conflicts of interest. The 159 journals were grouped according to commercial biases (reprint services, advertising revenue, and ownership by a large commercial publishing firm). 30.6% (39,440) of articles were published in journals showing no evidence of evaluated commercial publishing relationships. 33.9% (43,630) were published in journals accepting advertising and reprint fees; 31.7% (40,887) in journals owned by large publishing firms; 1.2% (1,589) in journals accepting reprint fees only; and 2.5% (3,235) in journals accepting only advertising fees. Journals with commercial relationships were more likely to publish articles with aCOI (9.2% (92/1000) vs. 6.4% (64/1000), p = 0.024). In the multivariate analysis, only a journal's acceptance of reprint fees served as a significant predictor (OR = 2.81 at 95% CI, 1.5 to 8.6). Shared control estimation was used to evaluate the relationships between commercial publishing practices and aCOI frequency in total and by type. BCa-corrected mean difference effect sizes ranged from -1.0 to 6.1, and confirm findings indicating that accepting reprint fees may constitute the most significant commercial bias. The findings indicate that concerns over the influence of industry advertising in medical journals may be overstated, and that accepting fees for reprints may constitute the largest risk of bias for editorial decision-making.https://doi.org/10.1371/journal.pone.0236166
spellingShingle S Scott Graham
Zoltan P Majdik
Dave Clark
Molly M Kessler
Tristin Brynn Hooker
Relationships among commercial practices and author conflicts of interest in biomedical publishing.
PLoS ONE
title Relationships among commercial practices and author conflicts of interest in biomedical publishing.
title_full Relationships among commercial practices and author conflicts of interest in biomedical publishing.
title_fullStr Relationships among commercial practices and author conflicts of interest in biomedical publishing.
title_full_unstemmed Relationships among commercial practices and author conflicts of interest in biomedical publishing.
title_short Relationships among commercial practices and author conflicts of interest in biomedical publishing.
title_sort relationships among commercial practices and author conflicts of interest in biomedical publishing
url https://doi.org/10.1371/journal.pone.0236166
work_keys_str_mv AT sscottgraham relationshipsamongcommercialpracticesandauthorconflictsofinterestinbiomedicalpublishing
AT zoltanpmajdik relationshipsamongcommercialpracticesandauthorconflictsofinterestinbiomedicalpublishing
AT daveclark relationshipsamongcommercialpracticesandauthorconflictsofinterestinbiomedicalpublishing
AT mollymkessler relationshipsamongcommercialpracticesandauthorconflictsofinterestinbiomedicalpublishing
AT tristinbrynnhooker relationshipsamongcommercialpracticesandauthorconflictsofinterestinbiomedicalpublishing